Tsonwin Hai

Prof. Dr. Tsonwin Hai

Ohio State University
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2010 in Gene Expression
Verified
Journal Article
Closed access
THTsonwin Hai
Tsonwin Hai
CWChristopher C. Wolford
Christopher C. Wolford
YCYi-Seok Chang
Yi-Seok Chang
Activating transcription factor 3 (ATF3) gene encodes a member of the ATF family of transcription factors and is induced by various stress signals. All members of this family share the basic region-leucine zipper (bZip) DNA binding motif and bind to the consensus sequence TGACGTCA in vitro. Previous reviews and an Internet source have covered the following topics: the nomenclature of ATF proteins, the history of their discovery, the potential interplays between ATFs and other bZip proteins, ATF3-interacting proteins, ATF3 target genes, and the emerging roles of ATF3 in cancer and immunity (see footnote 1). In this review, we present evidence and clues that prompted us to put forth the idea that ATF3 functions as a “hub” of the cellular adaptive-response network. We will then focus on the roles of ATF3 in modulating inflammatory response. Inflammation is increasingly recognized to play an important role for the development of many diseases. Putting this in the context of the hub idea, we propose that modulation of inflammation by ATF3 is a unifying theme for the potential involvement of ATF3 in various diseases.

1 July 2004 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
MHMatthew G. Hartman
Matthew G. Hartman
DLDan Lu
Dan Lu
MKMi-Lyang Kim
Mi-Lyang Kim
GKGary J. Kociba
Gary J. Kociba
TSTala Shukri
Tala Shukri
THTsonwin Hai
Tsonwin Hai
Activating transcription factor 3 (ATF3) is a stress-inducible gene and encodes a member of the ATF/CREB family of transcription factors. However, the physiological significance of ATF3 induction by stress signals is not clear. In this report, we describe several lines of evidence supporting a role of ATF3 in stress-induced β-cell apoptosis. First, ATF3 is induced in β cells by signals relevant to β-cell destruction: proinflammatory cytokines, nitric oxide, and high concentrations of glucose and palmitate. Second, induction of ATF3 is mediated in part by the NF-κB and Jun N-terminal kinase/stress-activated protein kinase signaling pathways, two stress-induced pathways implicated in both type 1 and type 2 diabetes. Third, transgenic mice expressing ATF3 in β cells develop abnormal islets and defects secondary to β-cell deficiency. Fourth, ATF3 knockout islets are partially protected from cytokine- or nitric oxide-induced apoptosis. Fifth, ATF3 is expressed in the islets of patients with type 1 or type 2 diabetes, and in the islets of nonobese diabetic mice that have developed insulitis or diabetes. Taken together, our results suggest ATF3 to be a novel regulator of stress-induced β-cell apoptosis.

1 January 1999
Verified
Journal Article
Closed access
THTsonwin Hai
Tsonwin Hai
CWCD Wolfgang
CD Wolfgang
DMDK Marsee
DK Marsee
AAAE Allen
AE Allen
USU Sivaprasad
U Sivaprasad

1 March 1996 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
BCBenjamin P. C. Chen
Benjamin P. C. Chen
CWCurt D. Wolfgang
Curt D. Wolfgang
THTsonwin Hai
Tsonwin Hai
We demonstrate that ATF3, a member of the ATF/CREB family of transcription factors, is induced in a variety of stressed tissues: mechanically injured liver, toxin-injured liver, blood-deprived heart, and postseizure brain. We also demonstrate that an ATF3-interacting protein, gadd153/Chop10, forms a nonfunctional heterodimer with ATF3: the heterodimer, in contrast to the ATF3 homodimer, does not bind to the ATF/cyclic AMP response element consensus site and does not repress transcription. Interestingly, ATF3 and gadd153/Chop10 are expressed in inverse but overlapping manners during the liver's response to carbon tetrachloride (CCl4): the level of gadd153/Chop10 mRNA is high in the normal liver and greatly decreases upon CCl4 treatment; the level of ATF3 mRNA, on the other hand, is low in the normal liver and greatly increases upon CCl4 treatment. We hypothesize that in nonstressed liver, gadd153/Chop10 inhibits the limited amount of ATF3 by forming an inactive heterodimer with it, whereas in CCl4-injured liver, the synthesis of gadd153/Chop10 is repressed, allowing the induced ATF3 to function.

22 October 2007 in Oncogene
Verified
Journal Article
Closed access
XYX Yin
X Yin
JDJ W DeWille
J W DeWille
THTsonwin Hai
Tsonwin Hai